A Randomized Clinical Trial of Transgender Women Switching to B/F/TAF: The (mo)BETTA Trial.
Jordan E LakeAna N MonczorHan FengPaula DebroyAaren KettelhutHongyu MiaoLiming PengShalender BhasinSusan BellNahid RianonTodd T BrownNicholas T FunderburgPublished in: Open forum infectious diseases (2023)
In this cohort of TW, switch to B/F/TAF was safe and metabolically neutral, though greater fat gain occurred on B/F/TAF. Further study is needed to better understand cardiometabolic disease burden in TW with HIV.
Keyphrases
- hiv testing
- hiv infected
- hiv positive
- antiretroviral therapy
- men who have sex with men
- polycystic ovary syndrome
- human immunodeficiency virus
- study protocol
- clinical trial
- adipose tissue
- hepatitis c virus
- hiv aids
- phase ii
- risk factors
- fatty acid
- randomized controlled trial
- type diabetes
- open label
- insulin resistance
- south africa